BCAL Diagnostics LimitedASX: BDX

Investor Presentation September 2026

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX ·

FY 2026 Results Chief Executive Officer Anne -Louise Arnett Chair Jayne Shaw SEPTEMBER 2026 BCAL Diagnostics Australian leader BCAL is a healthcare company developing breakthrough early cancer detection blood technology . Products BREASTEST plus Avantect® Pancreatic Avantect®...

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

Story so far

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases